Icatibant Injection
Product Images NDC 62332-654

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 62332-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Icatibant-fig-a (Icatibant Fig A)

An instructional diagram showing components of a prefilled syringe for injection. Labels identify the plunger, syringe barrel, and protective cap over the syringe tip. Another labeled section shows a capped needle with needle cap, needle, and needle cap seal. An alcohol wipe is also depicted, with a note indicating the wipe is not included.*

FDA Label Image

Icatibant-fig-b (Icatibant Fig B)

Packaging for Icatibant injection 30 mg/3 mL by Alembic Pharmaceuticals Inc. The image shows a white rectangular box containing a prefilled syringe with attached needle and a separate small capped component, presumably for subcutaneous administration.*

FDA Label Image

Icatibant-fig-c (Icatibant Fig C)

An instructional illustration showing a hand holding a syringe while the other hand is preparing to receive a subcutaneous injection, depicting the process of administering an injection.*

FDA Label Image

Icatibant-fig-d (Icatibant Fig D)

An instructional illustration showing hands preparing a syringe with a needle cover being removed before injection. The image demonstrates how to properly detach the needle cover from the syringe for subcutaneous injection.*

FDA Label Image

Icatibant-fig-e (Icatibant Fig E)

An instructional illustration showing hands preparing a syringe by twisting or removing the cap from the needle, as part of injection preparation for a subcutaneous drug like Icatibant injection.*

FDA Label Image

Icatibant-fig-f (Icatibant Fig F)

An illustration showing the lower back area of a human torso, with two shaded square regions marked symmetrically on each side. This diagram likely indicates suggested injection sites or areas for subcutaneous administration of the medication.*

FDA Label Image

Icatibant-fig-g (Icatibant Fig G)

An instructional diagram showing a hand administering a subcutaneous injection into the abdomen area, indicating the proper injection site for a subcutaneous drug like Icatibant injection.*

FDA Label Image

Icatibant-fig-h (Icatibant Fig H)

An instructional illustration showing a hand holding a syringe being prepared or activated, with an arrow indicating movement or direction, suggesting the step of filling or tapping the syringe before administration. No product labeling or text is visible.*

FDA Label Image

Icatibant-fig-i (Icatibant Fig I)

An instructional diagram showing a hand holding a syringe with needle extended, likely demonstrating the technique for a subcutaneous injection dose of Icatibant 30 mg/3 mL.*

FDA Label Image

Icatibant-fig-j (Icatibant Fig J)

An instructional line drawing illustrating a hand administering a subcutaneous injection into the abdominal area, shown by the outline of a torso and a hand pinching the skin. This image supports use directions for Icatibant injection.*

FDA Label Image

Icatibant-fig-k (Icatibant Fig K)

An instructional illustration showing two hand positions for subcutaneous injection. One hand holds a syringe at a 45-degree angle, while the other is at a 90-degree angle, depicting proper injection technique angles for administering an injection.*

FDA Label Image

Icatibant-fig-l (Icatibant Fig L)

An instructional illustration showing a person administering a subcutaneous injection to the forearm using a syringe. The image demonstrates the proper technique for subcutaneous injection, where the syringe needle is inserted into the skin of the forearm.*

FDA Label Image

Icatibant-fig-m (Icatibant Fig M)

An instructional line drawing showing a hand injecting a subcutaneous injection into the outer area of the opposite hand near the base of the thumb. The diagram highlights the correct technique for subcutaneous injection administration, consistent with the dosing method for Icatibant injection 30 mg/3 mL.*

FDA Label Image

Icatibant-fig-n (Icatibant Fig N)

An instructional illustration depicting a hand holding a syringe for subcutaneous injection. The syringe needle is positioned near the skin of an abdomen, indicating the injection site. An arrow points to the injection area, highlighting the correct placement for the subcutaneous injection.*

FDA Label Image

Icatibant-fig-o (Icatibant Fig O)

An instructional illustration showing hands disposing of a syringe needle into a biohazard sharps container labeled with a biohazard symbol and the warnings 'DO NOT RECYCLE' and 'CONTAINS SHARPS.' The image advises proper disposal of injection needles to prevent contamination or injury.*

FDA Label Image

Icatibant-graph (Icatibant Graph)

A line graph comparing the proportion of patients not achieving a 50% reduction in symptoms over time in hours after dosing with Icatibant injection versus placebo. The graph shows data for 43 patients receiving Icatibant and 45 patients receiving placebo, with time on the x-axis and proportion on the y-axis.*

FDA Label Image

Icatibant-monocarton (Icatibant Monocarton)

Packaging label for Icatibant Injection 30 mg/3 mL (10 mg/mL) by Alembic Pharmaceuticals Ltd. The label indicates a single-dose prefilled syringe for subcutaneous use only, Rx only. The carton holds one 3 mL syringe and a 25G hypodermic needle. Storage instructions recommend 2 to 25°C, no freezing. Manufactured in India and marketed by Alembic Pharmaceuticals Inc., Bedminster, NJ.*

FDA Label Image

Icatibant-outercarton (Icatibant Outercarton)

Packaging label for Icatibant Injection 30 mg/3 mL (10 mg/mL) subcutaneous injection by Alembic Pharmaceuticals Inc. The carton contains 3 single-dose prefilled syringes. Label includes storage instructions, inactive ingredients, and manufacturing information from Alembic Pharmaceuticals Limited, India.*

FDA Label Image

Icatibant-pfs-label (Icatibant Pfs Label)

Icatibant Injection 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe label. The label indicates subcutaneous use only, includes a lot and expiration date section, and notes it is manufactured by Alembic Pharmaceuticals Inc. in India.*

FDA Label Image

Icatibant-structure (Icatibant Structure)

Chemical structure diagram of Icatibant, a human prescription drug active ingredient used in subcutaneous injection form. The structure shows the molecular arrangement including rings, amino groups, and peptide bonds characteristic of Icatibant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.